시장보고서
상품코드
1828928

3D 프린트 의약품 시장 분석과 예측(-2034년) : 유형, 제품, 기술, 재료 유형, 용도, 최종사용자, 프로세스, 배포, 디바이스

3D Printed Drugs Market Analysis and Forecast to 2034: Type, Product, Technology, Material Type, Application, End User, Process, Deployment, Device

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 340 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

3D 프린트 의약품 시장은 2024년 3억 6,770만 달러에서 2034년에는 8억 9,350만 달러로 확대하며, 약 9.3%의 CAGR로 성장할 것으로 예측됩니다. 3D 프린팅 의약품 시장은 첨가제 제조 기술을 이용한 의약품 제조를 포함하며, 정확한 복용량 맞춤화 및 복잡한 약물 처방을 가능하게 합니다. 이 기술 혁신은 환자 맞춤형 치료를 강화하고 의약품 개발을 가속화할 수 있습니다. 규제가 강화되고 만성질환의 확산이 증가함에 따라 시장은 성장세를 보이고 있으며, 견고한 품질관리와 확장 가능한 생산 방식의 필요성이 강조되고 있습니다.

3D 프린팅 의약품 시장은 맞춤형 의료와 혁신적인 약물전달 시스템의 발전에 힘입어 괄목할 만한 성장세를 보이고 있습니다. 경구제 부문은 환자들의 순응도를 높이는 맞춤형 제형에 대한 수요에 힘입어 가장 높은 성과를 내는 하위 부문으로 부상하고 있습니다. 2위는 경피제로 약물 방출의 조절과 부작용의 최소화가 기대되는 경피제입니다. 기술 분야에서는 복잡한 약물 제제를 제조할 때 비용 효율성과 범용성으로 인해 재료 압출법이 선두를 달리고 있습니다. 바인더젯팅 공정이 그 뒤를 이어 대량 생산을 위한 속도와 정확성에서 우위를 점하고 있습니다. 의약품 설계의 맞춤화 능력은 개인 맞춤형 헬스케어 동향에 따라 확대되고 있습니다. 제약사들은 이러한 기술을 활용하기 위해 연구개발에 대한 투자를 늘리고 있습니다. 3D 프린팅 의약품이 초래하는 고유한 과제와 기회에 대응하기 위해 프레임워크가 진화하고 있으므로 규제 발전은 시장 성장을 더욱 촉진할 것으로 예측됩니다.

시장 세분화
유형 즉시 방출형, 서방형, 방출 제어형
제품 정제, 캡슐제, 다제배합제
기술 스테레오리소그래피(SLA), 용융 적층제조(FDM), 선택적 레이저 소결(SLS), 잉크젯 인쇄, 바인더 제트, 분말상 융합
재료 유형 폴리머, 생분해성 폴리머, 원료의약품(API), 부형제
용도 맞춤형 의료, 배합약, 희귀의약품, 임상시험
최종사용자 제약회사, 연구기관, 병원·클리닉, 제조 수탁 기관(CMO)
프로세스 설계, 시작, 제조, 품질관리
배포 온프레미스, 클라우드 기반
디바이스 데스크톱 3D 프린터, 산업용 3D 프린터

시장 현황

3D 프린팅 의약품 시장은 가격 전략과 제품 출시가 크게 발전함에 따라 시장 점유율이 역동적으로 변화하고 있습니다. 이 업계는 맞춤형 의료와 정밀 투여에 대한 수요에 힘입어 혁신적인 제제가 급증하고 있습니다. 시장 리더들은 포트폴리오를 확장하고 경쟁력을 강화하기 위해 전략적 제휴에 집중하고 있습니다. 가격 설정은 여전히 중요한 요소이며, 기술 발전과 생산 효율성 향상에 따른 비용 절감의 영향을 받고 있습니다. 3D 프린팅 의약품 분야의 경쟁은 치열해지고 있으며, 주요 기업은 기술 혁신과 전략적 제휴를 통해 패권을 다투고 있습니다. FDA, EMA 등의 기관이 시장 진입과 제품 개발에 영향을 미치는 가이드라인을 수립하고 있으므로 규제의 영향은 매우 중요합니다. 시장 특징은 급속한 기술 발전과 규제 상황의 진화입니다. 기업은 엄격한 규제를 준수하고, 유리한 기회를 활용하기 위해 연구개발에 투자하고 있습니다. 경쟁 구도는 3D 프린팅 기술의 혁신 가능성을 활용하려는 대형 제약사와 민첩한 스타트업의 존재로 특징지어집니다.

주요 동향과 촉진요인:

3D 프린팅 의약품 시장은 기술 발전과 맞춤형 의료에 대한 수요에 힘입어 강력한 성장세를 보이고 있습니다. 주요 동향으로는 의약품 분야에서 3D 프린팅 기술의 채택이 증가하고 있으며, 이를 통해 정확한 용량 맞춤화 및 복잡한 약물 처방이 가능해졌습니다는 점을 들 수 있습니다. 이 기술 혁신은 환자의 순응도와 치료 효과를 향상시킵니다. 규제기관은 3D 프린팅 의약품의 잠재력을 점점 더 많이 인식하고 있으며, 승인 절차가 완화되어 시장 확대가 촉진되고 있습니다. 만성질환의 확산으로 개인 맞춤형 투약 솔루션에 대한 필요성이 높아지면서 수요는 더욱 확대되고 있습니다. 헬스케어가 환자 중심 모델로 전환되고 있는 가운데, 3D 프린팅 의약품은 환자 개개인의 요구에 맞는 맞춤형 치료법을 제공할 수 있습니다. 또한 생체 적합성 소재와 프린팅 기술의 발전으로 의약품 개발의 가능성이 확대되고 있습니다. 제약회사들은 연구개발에 투자하고, 약물전달에 3D 프린팅의 새로운 응용을 모색하고 있습니다. 이 시장에서는 하이테크 기업과 제약 대기업의 협업도 볼 수 있으며, 기술 혁신과 시장 성장의 잠재력이 부각되고 있습니다.

억제와 과제:

3D 프린팅 의약품 시장에는 몇 가지 중요한 억제요인과 과제가 있습니다. 당국이 신기술을 승인하기 전에 엄격한 테스트와 검증 과정을 요구하므로 규제 장벽이 주요 장애물이 될 수 있습니다. 이는 시장 진입을 지연시키고 개발 비용을 증가시킬 수 있습니다. 또한 3D 프린팅 인프라에 필요한 고가의 초기 투자비용은 소규모 제약사 시장 진입을 가로막는 요인으로 작용할 수 있습니다. 또 다른 문제는 3D 프린팅에 적합한 원재료의 가용성이 제한되어 있으며, 제조 가능한 의약품의 범위가 제한된다는 점입니다. 또한 이 시장에서는 고급 3D 프린팅 장비를 조작하고 유지보수할 수 있는 숙련된 전문가가 부족하여 보급에 걸림돌이 되고 있습니다. 또한 3D 프린팅의 디지털 특성이 특허 침해 및 데이터 보안 문제를 야기하므로 지적재산권에 대한 우려도 제기되고 있습니다. 마지막으로이 기술의 참신함은 의료 서비스 프로바이더와 환자가 3D 프린팅 의약품에 대한 인식과 신뢰가 부족하여 주류 의료 관행에 대한 수용과 통합을 지연시킬 수 있음을 의미합니다. 이러한 문제들은 총체적으로 시장의 급격한 성장을 저해하고 있습니다.

주요 기업

Aprecia Pharmaceuticals, FabRx, Triastek, Multiply Labs, Craft Health, Tamicare, Glatt Pharmaceutical Services, Merck KGaA, Xilloc Medical, RegenHU, BioBots, Voxel8, CELLINK, Aspect Biosystems, EnvisionTEC

목차

제1장 3D 프린트 의약품 시장 개요

  • 조사 목적
  • 3D 프린트 의약품 시장의 정의와 조사 범위
  • 리포트의 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 개요

제3장 시장에 관한 주요 인사이트

제4장 3D 프린트 의약품 시장 전망

  • 3D 프린트 의약품 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 3D 프린트 의약품 시장 전략

  • 모시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 3D 프린트 의약품 시장 규모

  • 3D 프린트 의약품 시장 규모 : 금액별
  • 3D 프린트 의약품 시장 규모 : 수량별

제7장 3D 프린트 의약품 시장 : 유형별

  • 시장 개요
  • 즉시 방출형
  • 서방형
  • 방출 제어형
  • 기타

제8장 3D 프린트 의약품 시장 : 제품별

  • 시장 개요
  • 태블릿
  • 캡슐제
  • 다제배합제
  • 기타

제9장 3D 프린트 의약품 시장 : 기술별

  • 시장 개요
  • 스테레오리소그래피(SLA)
  • 용융 증착 모델링(FDM)
  • 선택적 레이저 소결(SLS)
  • 잉크젯 인쇄
  • 바인더 제트
  • 파우더 베드 융합
  • 기타

제10장 3D 프린트 의약품 시장 : 재료 유형별

  • 시장 개요
  • 폴리머
  • 생분해성 폴리머
  • 원료의약품(API)
  • 부형제
  • 기타

제11장 3D 프린트 의약품 시장 : 용도별

  • 시장 개요
  • 맞춤형 의료
  • 배합약
  • 희귀의약품
  • 임상시험
  • 기타

제12장 3D 프린트 의약품 시장 : 최종사용자별

  • 시장 개요
  • 제약회사
  • 연구기관
  • 병원 및 진료소
  • 수탁제조 기관(CMO)
  • 기타

제13장 3D 프린트 의약품 시장 : 프로세스별

  • 시장 개요
  • 설계
  • 프로토타이핑
  • 제조
  • 품질관리
  • 기타

제14장 3D 프린트 의약품 시장 : 배포별

  • 시장 개요
  • 온프레미스
  • 클라우드 기반
  • 기타

제15장 3D 프린트 의약품 시장 : 디바이스별

  • 시장 개요
  • 데스크톱 3D 프린터
  • 산업용 3D 프린터
  • 기타

제16장 3D 프린트 의약품 시장, 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제18장 기업 개요

  • Aprecia Pharmaceuticals
  • FabRx
  • Triastek
  • Multiply Labs
  • Craft Health
  • Tamicare
  • Glatt Pharmaceutical Services
  • Merck KGaA
  • Xilloc Medical
  • RegenHU
  • BioBots
  • Voxel8
  • CELLINK
  • Aspect Biosystems
  • EnvisionTEC
KSA 25.10.14

3D Printed Drugs Market is anticipated to expand from $367.7 million in 2024 to $893.5 million by 2034, growing at a CAGR of approximately 9.3%. The 3D Printed Drugs Market encompasses the production of pharmaceuticals using additive manufacturing techniques, allowing for precise dosage customization and complex drug formulations. This innovation enhances patient-specific therapies and accelerates drug development. With regulatory advancements and increasing chronic disease prevalence, the market is poised for growth, emphasizing the need for robust quality control and scalable production methods.

The 3D Printed Drugs Market is experiencing notable growth, propelled by advancements in personalized medicine and innovative drug delivery systems. The oral segment emerges as the top-performing sub-segment, driven by the demand for tailored dosage forms that enhance patient compliance. The second highest performing sub-segment is the transdermal category, benefiting from its potential for controlled drug release and minimal side effects. The technology segment sees the material extrusion method leading, due to its cost-effectiveness and versatility in producing complex drug formulations. The binder jetting process follows, offering advantages in speed and precision for large-scale production. Customization capabilities in drug design are expanding, aligning with the trend towards individualized healthcare solutions. Pharmaceutical companies are increasingly investing in research and development to harness these technologies. Regulatory advancements are anticipated to further bolster market growth, as frameworks evolve to accommodate the unique challenges and opportunities presented by 3D printed pharmaceuticals.

Market Segmentation
TypeImmediate-release, Sustained-release, Controlled-release
ProductTablets, Capsules, Multi-drug Combination
TechnologyStereolithography (SLA), Fused Deposition Modeling (FDM), Selective Laser Sintering (SLS), Inkjet Printing, Binder Jetting, Powder Bed Fusion
Material TypePolymers, Biodegradable Polymers, Active Pharmaceutical Ingredients (APIs), Excipients
ApplicationPersonalized Medicine, Compounded Medications, Orphan Drugs, Clinical Trials
End UserPharmaceutical Companies, Research Institutes, Hospitals and Clinics, Contract Manufacturing Organizations (CMOs)
ProcessDesigning, Prototyping, Manufacturing, Quality Control
DeploymentOn-premise, Cloud-based
DeviceDesktop 3D Printers, Industrial 3D Printers

Market Snapshot:

The 3D Printed Drugs Market is experiencing dynamic shifts in market share, with significant advancements in pricing strategies and product launches. The industry is witnessing a surge in innovative drug formulations, driven by the demand for personalized medicine and precision dosing. Market leaders are focusing on strategic collaborations to expand their portfolios and enhance their competitive edge. Pricing remains a crucial factor, influenced by technological advancements and production efficiencies that are gradually reducing costs. Competition in the 3D printed drugs sector is intensifying, with key players vying for dominance through innovation and strategic partnerships. Regulatory influences are pivotal, as agencies like the FDA and EMA establish guidelines that impact market entry and product development. The market is characterized by rapid technological advancements and evolving regulatory landscapes. Companies are investing in R&D to comply with stringent regulations and capitalize on lucrative opportunities. The competitive landscape is marked by the presence of both established pharmaceutical giants and agile startups, each seeking to leverage the transformative potential of 3D printing technology.

Geographical Overview:

The 3D printed drugs market is evolving rapidly across various regions, each presenting unique growth dynamics. North America leads the market, propelled by advanced healthcare infrastructure and substantial investments in pharmaceutical innovations. The region's focus on personalized medicine and regulatory support further accelerates market expansion. Europe follows, with a strong emphasis on research and development activities in pharmaceutical technologies. Initiatives to integrate 3D printing in drug manufacturing are gaining momentum, enhancing its market potential. In Asia Pacific, the market is burgeoning, driven by rising healthcare demands and technological advancements. Countries like China and India are investing heavily in 3D printing technologies, positioning themselves as key players. The region's growing focus on cost-effective and efficient drug production methods is a significant growth driver. Latin America and the Middle East & Africa are emerging markets with promising potential. In Latin America, increasing healthcare investments and innovation adoption are notable. Meanwhile, the Middle East & Africa are recognizing the transformative potential of 3D printed drugs in enhancing healthcare delivery.

Key Trends and Drivers:

The 3D printed drugs market is experiencing robust growth propelled by technological advancements and personalized medicine demand. Key trends include the increasing adoption of 3D printing technology in pharmaceuticals, which allows for precise dosage customization and complex drug formulations. This innovation enhances patient adherence and treatment efficacy. Regulatory bodies are increasingly recognizing the potential of 3D printed drugs, easing pathways for approvals, and fostering market expansion. The growing prevalence of chronic diseases is driving the need for personalized medication solutions, further amplifying demand. As healthcare shifts towards patient-centric models, 3D printed drugs offer tailored therapies that address individual patient needs. Moreover, advancements in bio-compatible materials and printing technologies are expanding the possibilities for drug development. Pharmaceutical companies are investing in research and development to explore novel applications of 3D printing in drug delivery. The market is also witnessing collaboration between tech firms and pharmaceutical giants, highlighting the potential for innovation and market growth.

Restraints and Challenges:

The 3D printed drugs market encounters several significant restraints and challenges. Regulatory hurdles present a primary obstacle, as authorities require rigorous testing and validation processes before approving new technologies. This can delay market entry and increase development costs. Furthermore, the high initial investment needed for 3D printing infrastructure can deter smaller pharmaceutical companies from entering the market. Another challenge is the limited availability of raw materials suitable for 3D drug printing, which restricts the range of producible medications. Additionally, the market faces a shortage of skilled professionals who can operate and maintain sophisticated 3D printing equipment, hindering widespread adoption. Intellectual property concerns also arise, as the digital nature of 3D printing raises issues about patent infringement and data security. Finally, the technology's novelty means that healthcare providers and patients may lack awareness or trust in 3D printed drugs, slowing acceptance and integration into mainstream medical practices. These challenges collectively impede the rapid growth of the market.

Key Players:

Aprecia Pharmaceuticals, FabRx, Triastek, Multiply Labs, Craft Health, Tamicare, Glatt Pharmaceutical Services, Merck KGaA, Xilloc Medical, RegenHU, BioBots, Voxel8, CELLINK, Aspect Biosystems, EnvisionTEC

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: 3D Printed Drugs Market Overview

  • 1.1 Objectives of the Study
  • 1.2 3D Printed Drugs Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Material Type
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by Device
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Material Type
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by Device
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: 3D Printed Drugs Market Outlook

  • 4.1 3D Printed Drugs Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: 3D Printed Drugs Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: 3D Printed Drugs Market Size

  • 6.1 3D Printed Drugs Market Size, by Value
  • 6.2 3D Printed Drugs Market Size, by Volume

7: 3D Printed Drugs Market, by Type

  • 7.1 Market Overview
  • 7.2 Immediate-release
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Sustained-release
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Controlled-release
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: 3D Printed Drugs Market, by Product

  • 8.1 Market Overview
  • 8.2 Tablets
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Capsules
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Multi-drug Combination
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: 3D Printed Drugs Market, by Technology

  • 9.1 Market Overview
  • 9.2 Stereolithography (SLA)
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Fused Deposition Modeling (FDM)
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Selective Laser Sintering (SLS)
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Inkjet Printing
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Binder Jetting
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Powder Bed Fusion
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: 3D Printed Drugs Market, by Material Type

  • 10.1 Market Overview
  • 10.2 Polymers
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Biodegradable Polymers
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Active Pharmaceutical Ingredients (APIs)
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Excipients
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: 3D Printed Drugs Market, by Application

  • 11.1 Market Overview
  • 11.2 Personalized Medicine
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Compounded Medications
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Orphan Drugs
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Clinical Trials
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: 3D Printed Drugs Market, by End User

  • 12.1 Market Overview
  • 12.2 Pharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Research Institutes
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Hospitals and Clinics
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Contract Manufacturing Organizations (CMOs)
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: 3D Printed Drugs Market, by Process

  • 13.1 Market Overview
  • 13.2 Designing
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Prototyping
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Manufacturing
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Quality Control
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: 3D Printed Drugs Market, by Deployment

  • 14.1 Market Overview
  • 14.2 On-premise
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Cloud-based
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: 3D Printed Drugs Market, by Device

  • 15.1 Market Overview
  • 15.2 Desktop 3D Printers
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Industrial 3D Printers
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: 3D Printed Drugs Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Technology
    • 16.2.5 North America Market Size and Forecast, by Material Type
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Process
    • 16.2.9 North America Market Size and Forecast, by Deployment
    • 16.2.10 North America Market Size and Forecast, by Device
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Technology
      • 16.2.9.4 United States Market Size and Forecast, by Material Type
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Process
      • 16.2.9.8 United States Market Size and Forecast, by Deployment
      • 16.2.9.9 United States Market Size and Forecast, by Device
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Technology
      • 16.2.10.4 Canada Market Size and Forecast, by Material Type
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Process
      • 16.2.10.8 Canada Market Size and Forecast, by Deployment
      • 16.2.10.9 Canada Market Size and Forecast, by Device
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Technology
    • 16.3.5 Europe Market Size and Forecast, by Material Type
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Process
    • 16.3.9 Europe Market Size and Forecast, by Deployment
    • 16.3.10 Europe Market Size and Forecast, by Device
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Material Type
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Technology
      • 16.3.10.4 Germany Market Size and Forecast, by Material Type
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Process
      • 16.3.10.8 Germany Market Size and Forecast, by Deployment
      • 16.3.10.9 Germany Market Size and Forecast, by Device
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Technology
      • 16.3.11.4 France Market Size and Forecast, by Material Type
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Process
      • 16.3.11.8 France Market Size and Forecast, by Deployment
      • 16.3.11.9 France Market Size and Forecast, by Device
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Technology
      • 16.3.12.4 Spain Market Size and Forecast, by Material Type
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Process
      • 16.3.12.8 Spain Market Size and Forecast, by Deployment
      • 16.3.12.9 Spain Market Size and Forecast, by Device
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Technology
      • 16.3.13.4 Italy Market Size and Forecast, by Material Type
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Process
      • 16.3.13.8 Italy Market Size and Forecast, by Deployment
      • 16.3.13.9 Italy Market Size and Forecast, by Device
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.4 Netherlands Market Size and Forecast, by Material Type
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Process
      • 16.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 16.3.14.9 Netherlands Market Size and Forecast, by Device
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Technology
      • 16.3.15.4 Sweden Market Size and Forecast, by Material Type
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Process
      • 16.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 16.3.15.9 Sweden Market Size and Forecast, by Device
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.4 Switzerland Market Size and Forecast, by Material Type
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Process
      • 16.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 16.3.16.9 Switzerland Market Size and Forecast, by Device
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Technology
      • 16.3.17.4 Denmark Market Size and Forecast, by Material Type
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Process
      • 16.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 16.3.17.9 Denmark Market Size and Forecast, by Device
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Technology
      • 16.3.18.4 Finland Market Size and Forecast, by Material Type
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Process
      • 16.3.18.8 Finland Market Size and Forecast, by Deployment
      • 16.3.18.9 Finland Market Size and Forecast, by Device
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Technology
      • 16.3.19.4 Russia Market Size and Forecast, by Material Type
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Process
      • 16.3.19.8 Russia Market Size and Forecast, by Deployment
      • 16.3.19.9 Russia Market Size and Forecast, by Device
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Material Type
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Material Type
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Technology
      • 16.4.9.4 China Market Size and Forecast, by Material Type
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Process
      • 16.4.9.8 China Market Size and Forecast, by Deployment
      • 16.4.9.9 China Market Size and Forecast, by Device
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Technology
      • 16.4.10.4 India Market Size and Forecast, by Material Type
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Process
      • 16.4.10.8 India Market Size and Forecast, by Deployment
      • 16.4.10.9 India Market Size and Forecast, by Device
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Technology
      • 16.4.11.4 Japan Market Size and Forecast, by Material Type
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Process
      • 16.4.11.8 Japan Market Size and Forecast, by Deployment
      • 16.4.11.9 Japan Market Size and Forecast, by Device
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Technology
      • 16.4.12.4 South Korea Market Size and Forecast, by Material Type
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Process
      • 16.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 16.4.12.9 South Korea Market Size and Forecast, by Device
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Technology
      • 16.4.13.4 Australia Market Size and Forecast, by Material Type
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Process
      • 16.4.13.8 Australia Market Size and Forecast, by Deployment
      • 16.4.13.9 Australia Market Size and Forecast, by Device
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Technology
      • 16.4.14.4 Singapore Market Size and Forecast, by Material Type
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Process
      • 16.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 16.4.14.9 Singapore Market Size and Forecast, by Device
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.4 Indonesia Market Size and Forecast, by Material Type
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Process
      • 16.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 16.4.15.9 Indonesia Market Size and Forecast, by Device
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.4 Taiwan Market Size and Forecast, by Material Type
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Process
      • 16.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 16.4.16.9 Taiwan Market Size and Forecast, by Device
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.4 Malaysia Market Size and Forecast, by Material Type
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Process
      • 16.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 16.4.17.9 Malaysia Market Size and Forecast, by Device
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Technology
    • 16.5.5 Latin America Market Size and Forecast, by Material Type
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Process
    • 16.5.9 Latin America Market Size and Forecast, by Deployment
    • 16.5.10 Latin America Market Size and Forecast, by Device
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Technology
      • 16.5.9.4 Brazil Market Size and Forecast, by Material Type
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Process
      • 16.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 16.5.9.9 Brazil Market Size and Forecast, by Device
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Technology
      • 16.5.10.4 Mexico Market Size and Forecast, by Material Type
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Process
      • 16.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 16.5.10.9 Mexico Market Size and Forecast, by Device
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Technology
      • 16.5.11.4 Argentina Market Size and Forecast, by Material Type
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Process
      • 16.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 16.5.11.9 Argentina Market Size and Forecast, by Device
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Material Type
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Material Type
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Material Type
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Technology
      • 16.6.10.4 UAE Market Size and Forecast, by Material Type
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Process
      • 16.6.10.8 UAE Market Size and Forecast, by Deployment
      • 16.6.10.9 UAE Market Size and Forecast, by Device
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Technology
      • 16.6.11.4 South Africa Market Size and Forecast, by Material Type
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Process
      • 16.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 16.6.11.9 South Africa Market Size and Forecast, by Device
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Material Type
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Aprecia Pharmaceuticals
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 FabRx
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Triastek
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Multiply Labs
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Craft Health
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Tamicare
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Glatt Pharmaceutical Services
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Merck KGaA
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Xilloc Medical
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 RegenHU
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 BioBots
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Voxel8
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 CELLINK
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Aspect Biosystems
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 EnvisionTEC
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제